We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14
Avg Time Held Equity + Options
1.3 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1.1 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.2 years

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV icon
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT icon
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT icon
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ELV icon
26
Elevance Health
ELV
$92.9B
$9.45M 0.8%
21,694
+19,379
+837% +$8.79M
2020 Q4
11 quarters
LQDA icon
27
Liquidia Corp
LQDA
$3.02B
$8.85M 0.75%
1,395,454
+470,010
+51% +$3.39M
2021 Q1
10 quarters
HUM icon
28
Humana
HUM
$50.1B
$8.82M 0.75%
18,121
+6,194
+52% +$2.91M
2022 Q2
5 quarters
IBB icon
29
PUT
iShares Biotechnology ETF
IBB
$10.3B
$8.6M 0.73%
+70,300
New +$8.94M
2023 Q3
0 quarters
TLT icon
30
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$49.7B
$8.31M 0.7%
+93,700
New +$9.01M
2023 Q3
0 quarters
AMRN icon
31
Amarin Corp
AMRN
$238M
$7.76M 0.66%
421,594
-103,511
-20% -$2.24M
2018 Q1
22 quarters
VRDN icon
32
Viridian Therapeutics
VRDN
$2.18B
$6.8M 0.58%
+443,270
New +$8.46M
2023 Q3
0 quarters
HYG icon
33
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
$6.63M 0.56%
+90,000
New +$6.72M
2023 Q3
0 quarters
WAT icon
34
Waters Corp
WAT
$42.7B
$6.34M 0.54%
23,124
+12,196
+112% +$3.37M
2023 Q2
1 quarter
NAMS icon
35
NewAmsterdam Pharma
NAMS
$2.39B
$6.11M 0.52%
660,618
-31,751
-5% -$344K
2023 Q1
2 quarters
XBI icon
36
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.55B
$5.84M 0.49%
80,000
-10,000
-11% -$799K
2023 Q1
2 quarters
TSVT icon
37
DELISTED
2seventy bio
TSVT
$5.7M 0.48%
+1,453,378
New +$9.53M
2023 Q3
0 quarters
MCRB icon
38
Seres Therapeutics
MCRB
$25.1M
$5.6M 0.47%
117,628
-36,210
-24% -$2.76M
2022 Q3
4 quarters
TSHA icon
39
Taysha Gene Therapies
TSHA
$1.19B
$5.39M 0.46%
+1,705,774
New +$3.19M
2023 Q3
0 quarters
IFRX icon
40
InflaRx
IFRX
$199M
$5.18M 0.44%
1,737,544
-177,569
-9% -$676K
2023 Q2
1 quarter
ICLR icon
41
Icon
ICLR
$13.2B
$5.17M 0.44%
20,998
-50,728
-71% -$12.8M
2021 Q3
8 quarters
PTGX icon
42
Protagonist Therapeutics
PTGX
$8.25B
$4.78M 0.4%
286,748
+172,089
+150% +$3.34M
2023 Q2
1 quarter
A icon
43
Agilent Technologies
A
$48.7B
$4.68M 0.4%
41,825
+13,365
+47% +$1.6M
2020 Q4
11 quarters
APLS icon
44
DELISTED
Apellis Pharmaceuticals
APLS
$4.67M 0.39%
122,643
+66,194
+117% +$2.91M
2023 Q2
1 quarter
IQV icon
45
IQVIA
IQV
$43.6B
$4.53M 0.38%
23,041
+4,293
+23% +$932K
2020 Q4
11 quarters
MRVI icon
46
Maravai LifeSciences
MRVI
$1.02B
$4.52M 0.38%
+452,323
New +$4.97M
2023 Q3
0 quarters
PBYI icon
47
Puma Biotechnology
PBYI
$514M
$4.42M 0.37%
1,681,149
+22,954
+1% +$78.2K
2021 Q3
8 quarters
AMN icon
48
PUT
AMN Healthcare
AMN
$1.56B
$4.26M 0.36%
50,000
-45,000
-47% -$4.27M
2023 Q1
2 quarters
PNTG icon
49
Pennant Group
PNTG
$1.45B
$4.07M 0.34%
365,899
-65,723
-15% -$761K
2023 Q1
2 quarters
MOH icon
50
Molina Healthcare
MOH
$10.8B
$4.01M 0.34%
12,234
-9,020
-42% -$2.84M
2023 Q2
1 quarter
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.